Application of the UK foresight obesity model in Ireland: the health and economic consequences of projected obesity trends in Ireland by Keaver, Laura et al.
Title Application of the UK foresight obesity model in Ireland: the health and
economic consequences of projected obesity trends in Ireland
Author(s) Keaver, Laura; Webber, Laura; Dee, Anne; Shiely, Frances; Marsh, Tim;
Balanda, Kevin P.; Perry, Ivan J.
Publication date 2013
Original citation Keaver L, Webber L, Dee A, Shiely F, Marsh T, Balanda K, et al. (2013)
Application of the UK Foresight Obesity Model in Ireland: The Health
and Economic Consequences of Projected Obesity Trends in Ireland.
PLoS ONE 8(11): e79827. doi:10.1371/journal.pone.0079827
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://dx.doi.org/10.1371/journal.pone.0079827
Access to the full text of the published version may require a
subscription.
Rights © 2015 Keaver et al. This is an open access article distributed under
the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited
http://creativecommons.org/licenses/by/4.0/
Item downloaded
from
http://hdl.handle.net/10468/2355
Downloaded on 2017-02-12T12:46:18Z
Application of the UK Foresight Obesity Model in Ireland:
The Health and Economic Consequences of Projected
Obesity Trends in Ireland
Laura Keaver1, Laura Webber2, Anne Dee3, Frances Shiely1, Tim Marsh2, Kevin Balanda4, Ivan Perry1*
1 Department of Epidemiology and Public Health, University College Cork, Cork, Ireland, 2 UK Health Forum, London, United Kingdom, 3 Health Service
Executive Department of Public Health, Limerick, Ireland, 4 Institute of Public Health in Ireland, Dublin, Ireland
Abstract
Background: Given the scale of the current obesity epidemic and associated health consequences there has been
increasing concern about the economic burden placed on society in terms of direct healthcare costs and indirect
societal costs. In the Republic of Ireland these costs were estimated at €1.13 billion for 2009. The total direct
healthcare costs for six major obesity related conditions (coronary heart disease & stroke, cancer, hypertension, type
2 diabetes and knee osteoarthritis) in the same year were estimated at €2.55 billion. The aim of this research is to
project disease burden and direct healthcare costs for these conditions in Ireland to 2030 using the established
model developed by the Health Forum (UK) for the Foresight: Tackling Obesities project.
Methodology: Routine data sources were used to derive incidence, prevalence, mortality and survival for six
conditions as inputs for the model. The model utilises a two stage modelling process to predict future BMI rates,
disease prevalence and costs. Stage 1 employs a non-linear multivariate regression model to project BMI trends;
stage 2 employs a microsimulation approach to produce longitudinal projections and test the impact of interventions
upon future incidence of obesity-related disease.
Results: Overweight and obesity are projected to reach levels of 89% and 85% in males and females respectively by
2030. This will result in an increase in the obesity related prevalence of CHD & stroke by 97%, cancers by 61% and
type 2 diabetes by 21%. The direct healthcare costs associated with these increases will amount to €5.4 billion by
2030. A 5% reduction in population BMI levels by 2030 is projected to result in €495 million less being spent in
obesity-related direct healthcare costs over twenty years.
Discussion: These findings have significant implications for policy, highlighting the need for effective strategies to
prevent this avoidable health and economic burden.
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Introduction
Overweight and obesity have become one of the most
prominent public health issues in society today, affecting
countries at every stage of development. The latest estimates
indicate approximately 1.46 billion people globally are
overweight and 502 million of these obese [1]. The problem is
rapidly penetrating into childhood with 42 million of those under
the age of five estimated to be overweight globally [2].
The most recent representative data for Ireland shows that
37% of the Irish adult population are overweight and a further
24% are obese [3]. This mirrors results from the Irish National
Lifestyle Surveys (SLÁN) in 2007 [4]. In addition levels of
childhood obesity in Ireland have been shown to be high when
compared with our Northern European counterparts [5].
Preliminary results from a national pre-school nutrition survey
indicate that 23% of those aged 2-4 years old are overweight or
obese [6]. As a significant correlation exists between childhood
and adolescent BMI and adult overweight and obesity, these
current childhood obesity rates have the potential to contribute
hugely to the health and economic burden of obesity in Ireland
in the future [7,8,9].
A greater recognition of the burden of disease associated
with obesity has come about in recent years [10]. This health
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burden is largely driven by increased incidence of type 2
diabetes, cardiovascular diseases and some forms of cancer
[11]. Both the direct and indirect healthcare costs associated
with these present a significant financial burden to both public
health expenditures and to the state [12]. A particularly detailed
recent study in Ireland has estimated total costs attributable to
obesity at 1.13 billion euro [13]. Of this €399 million were direct
and €729 million were indirect costs. Direct costs refer to in-
patient and day case costs, out-patient costs, GP costs and
drug costs. Indirect costs are more difficult to collate and in this
instance referred to productivity losses associated with work
absenteeism and premature mortality. Social, psychological
and emotional costs were omitted from indirect cost
calculations due to a lack of national data on the economic cost
of these variables.
Given the scale of the obesity epidemic there is interest
nationally in determining the extent and future consequences of
this issue. The UK foresight obesity model [14] has previously
been applied in over 70 countries worldwide as well as each
US state. Applying this model to the Irish population will
provide policymakers with an idea of the potential scale of the
obesity epidemic should it continue unabated, its
consequences for the Irish health system, as well as the
potential effect that particular policies may have if
implemented. This will help guide resource allocation,
population health planning and the development of effective
obesity prevention and health promotion programmes to curb
obesity levels within the country.
Methods
Data sources
The data sources on which the model’s input parameters are
based can be seen in Table 1. BMI data for Ireland was
collected by conducting a search of the literature using
Pubmed and Google scholar and through discussion with
academic departments and other relevant national
stakeholders. Databases were included if BMI data was
nationally representative, presented by age and sex and
categorised by WHO cut-offs for normal weight (<25kg/m2),
pre-obesity (25-29.99 kg/m2), and obesity (≥30kg/m2).
Measured data was preferred however, due to lack of
availability, some sources of self-reported data were included.
Outliers were removed where data fell outside of 95%
confidence limits.
A review of epidemiological studies was undertaken to find
incidence, prevalence, and annual healthcare costs for each
obesity-related disease: type 2 diabetes, coronary heart
disease, stroke, knee osteoarthritis, hypertension and obesity-
related cancers (breast, colorectal, oesophageal, endometrial,
liver, kidney and pancreas) by age and gender. The relative co-
morbidity risks related to being overweight or obese were
obtained for each of these diseases from the International
Association for the Study of Obesity [15]. Mortality and survival
data were also collected for fatal diseases: CHD, stroke,
cancers.
Incidence or prevalence data were not available for
hypertension so UK prevalence data were used as a proxy.
Survival data were not available for CHD or stroke so again the
UK was used as a proxy to estimate survival in Ireland. These
figures were adjusted for Irish population data [16].
Hypertension, Type 2 diabetes and knee osteoarthritis
prevalence were converted to incidence using WHO Dismod
equations [17].
Statistical analysis
A two-part modelling process was used to project the future
obesity-related disease burden in Ireland. The first module fits
multivariate, categorical regression models, to past and current
cross-sectional BMI data, to project obesity rates to 2030 by
sex. Age was included as a covariate and the predicted
proportions of population in each BMI category was
constrained to always total 100%.
Using the BMI levels predicted in module one, and assuming
that an individual’s BMI status in the same-age cohort is
consistent over time, module two simulates the BMI trajectory
of the Irish population as it ages. A BMI value is
probabilistically and stochastically assigned as a function of
age, sex and calendar year. This results in a longitudinal
growth model of the Irish population. The data collected on
incidence and prevalence of disease, mortality and survival
enabled the consequences of these BMI trends to be
Table 1. Sources of data inputs for Ireland.
Category Source of data
Population characteristics
 National Adult Nutrition Survey (2011) [21]
 SLAN (2007 [22], 2002 [23], 1998 [24])
BMI distribution North South Ireland Food Consumption Survey (2001)[25]
 The Irish Longitudinal study on Aging (2011) [26]
Population size Central Statistics Office (2010) [27]
Incidence/Prevalence
CHD Coronary Heart Attack Ireland Register (2006) [28]
Stroke North Dublin Population Stroke Study (2007) [29]
Cancer National Cancer Registry (2012) [30]
Hypertension Health Survey for England (2010) [31]
Type II diabetes Balanda et al., (2012) [32]
Knee Osteoarthritis Institute of Public Health (2012) [33]
Survival
CHD European Cardiovascular Disease Statistics (2012)[34]
Stroke Wolfe et al., (2011) [35]
Cancers National Cancer Registry (2010) [30]
Relative risks of obesity
on disease risks
International Association for the Study of Obesity
(2010) [36]
Disease-specific mortality
Coronary heart disease Central Statistics Office (2010) [27]
Stroke Central Statistics Office (2010) [27]
Cancer National Cancer Registry (2009) [30]
Healthcare costs
Direct Health Atlas Ireland, HSE (2009) [37]
doi: 10.1371/journal.pone.0079827.t001
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determined e.g. the modelling of each individual’s chance of
contracting, surviving or dying from these set of conditions. The
subsequent healthcare costs associated with these trends
could then be determined. The software used in this program
was written in C++. Five million Monte Carlo simulation runs
were performed.
The micro-simulation also modelled the effects of constraints
on future BMI growth. By anticipating the outcome of
interventions on BMI prevalence and its effects by age, year
and sex, it was possible to explore how levels of obesity-
related chronic disease, mortality, and healthcare costs would
alter following such interventions. Three different trend
scenarios were estimated: scenario 0: obesity trends continue
unabated; scenario 1: population BMI decreases by 1% and
scenario 2: population BMI decreases by 5%. Greater detail of
this methodology is described in [11,14] and Appendix S1.
Ethical approval
Ethical approval was granted by the Clinical Research Ethics
Committee of University College Cork. The data utilised came
from established databases where data encryption was already
in place and subjects could not be identified. All data used
remained confidential. Consent was given by the participants of
the various studies at the point of data collection for this data to
be stored and used for research.
Results
BMI distribution
The projected prevalence of overweight and obesity
(≥25kg/m2) in males and females aged 20+ in Ireland is
illustrated in Figure 1. In both cases overweight and obesity are
projected to increase by 2030. At this point 89% of males and
85% of females are predicted to be overweight or obese,
accounting for 3.5 million of the population. There will be an
additional 717 950 overweight or obese adults in 2030 when
compared to 2010. Of these additional cases 133 500 (19%)
will be over 65 years of age. While males will have higher rates
of overweight or obesity (≥25kg/m2) than females they will have
lower overall rates of obesity (≥30kg/m2) (48% in males
compared to 57% in females). Table S1 in Appendix S2
presents the proportion of the population in each BMI group by
sex and age group projected to 2030. Figures S1 and S2 in
Appendix S3 illustrate a sample of the projections with
confidence limits. Childhood obesity was not projected due to a
lack of representative data.
All inputs into the model represent total population figures
while all outputs represent the obesity related figures.
Prevalence of disease
The obesity related prevalence of disease per 100 000
population from 2010-2030 is presented in Figure 2 and
illustrates how the burden of disease is projected to increase
Figure 1.  Projected prevalence of overweight and obesity in the Irish population.  This figure shows the percentage
prevalence of overweight and obesity for males and females in Ireland in 2010 and projected prevalence for overweight and obesity
for males and females for 2020 and 2030.
doi: 10.1371/journal.pone.0079827.g001
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overtime. Based on total population figures [16], there will be
approximately 67 899 cases of CHD & Stroke, 97 133 cases of
cancer and 148 717 cases of type 2 diabetes by 2030. This
represents a 97%, 61% and 21% increase in obesity related
prevalence respectively. In addition the prevalences of non-
fatal conditions such as hypertension and knee osteoarthritis
are also projected to increase (affecting 27% and 1% of the
total population respectively).
Projected outcomes from potential interventions
Figure 3 presents projected incident cases (obesity related)
avoided per 100 000 of the population from 2010 - 2030 if,
when compared to no intervention (scenario 0), a 1% (scenario
1) and 5% (scenario 2) decrease in population BMI is achieved.
The cumulative incident cases avoided range from 20/100 000
in the case of knee osteoarthritis to 824/100 000 in
hypertension.
A 1% reduction in BMI in the population has a relatively small
impact on disease incidence. However, it is evident that an
intervention resulting in a 5% reduction in BMI levels in the Irish
population would have a significant impact on the incidence of
disease, particularly CHD & Stroke and Type 2 diabetes. Using
total population figures this intervention is projected to
decrease cumulative incidence by 35 984 and 36 788 cases
respectively by 2030. The number of incident cases avoided
approximately doubles between 2020 and 2030. This
intervention is also estimated to significantly reduce cumulative
incidence of hypertension (by approximately 2139/100 000 or
95 613 total cases within the population). A smaller though still
noticeable impact is also observed on cancer incidence where
20 249 fewer incident cases could be expected. Tables S2 -S5
in Appendix S4 contains results for prevalence, prevalent
cases avoided through intervention, cumulative incidence and
incident cases avoided through intervention.
Economics
This expansion in obesity related diseases has a significant
impact on healthcare costs. If obesity trends continue unabated
associated direct healthcare costs are projected to reach €5.4
billion by 2030. The main contributors to these increased costs
are CHD & Stroke which are projected to account for 92% of
obesity-related direct costs in 2030. The increase in total direct
healthcare costs from 2010 to 2030 corresponds to
approximately 30.3% of total healthcare spending in Ireland in
2011. Obesity-related direct healthcare costs are presented in
table 2. Tables S6-S8 in Appendix S5 present the healthcare
costs by year from 2010-2030.
It can be seen from table 2 that scenario 1, where a 1%
decrease in BMI is achieved across the population, is
estimated to lead to direct healthcare costs that are €104
million less by 2020 and €143 million less by 2030 than
scenario 0. A 5% reduction in BMI population levels (scenario
2) has a more significant impact with €394 million and €495
Figure 2.  Projected prevalence of disease per 100,000 population from 2010-2030.  This figure shows the projected
prevalence of disease per 100,000 population for 2010, 2020 and 2030 for six obesity related conditions. These six conditions are:
cancer, CHD & stroke, type 2 diabetes, hypertension and knee osteoarthritis.
doi: 10.1371/journal.pone.0079827.g002
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million less projected to be spent on obesity and its related co-
morbidities by 2020 and 2030 respectively.
Discussion
This is the first application of the UK foresight obesity model
to Irish data. It is also the first to report the projected direct
health care costs of six obesity related conditions, CHD &
stroke, diabetes, hypertension, cancer and knee osteoarthritis.
If obesity trends continue unabated, overweight and obesity is
projected to account for 89% of males and 85% of females in
2030, leading to 288 315 cumulative incident cases of cancer,
542 390 of CHD & stroke, 159 490 of type 2 diabetes, 961 005
of hypertension and 46 533 of knee osteoarthritis. This is
projected to result in obesity-related direct healthcare costs of
€5.4 billion by 2030.
A recent comprehensive study [13] of the cost of obesity in
Ireland in 2009 included some estimates of indirect costs to the
economy. It has been applied here to provide a crude estimate
of the indirect costs of obesity which cannot be determined
using the UK foresight obesity model. This was achieved by
deriving the ratio of direct to indirect costs from the recent Irish
study [13] and applying it to the direct healthcare costs
obtained from the foresight model. We estimate that indirect
costs will reach €9.88 billion in 2030. Both current and
projected indirect costs are likely to be significant
underestimates due to difficulty in obtaining accurate data and
the fact that the social, psychological and emotional effects of
obesity which contribute to indirect costs are hard to quantify.
This Irish research replicates work conducted in other
countries using the UK foresight obesity model. The results of
this study are consistent with that found in the Russian
Federation, Poland, the UK, USA and Latin America
[18,19,20,11], where the level of overweight and obesity is
projected to increase, leading to an increased burden of
disease and associated healthcare costs.
While the US has always been significantly ahead of Europe
with regards obesity prevalence, modelled trends project a
prevalence of 50-51% in males and 45-52% in females to 2030
in the US [11]. These figures are very similar to obesity rates
projected for Ireland (48% in males and 57% in females),
Table 2. Direct healthcare costs by year and disease.
 Scenario 0 Scenario 1 Scenario 2
Year 2010 2020 2030 2010 2020 2030 2010 2020 2030
Total costs (€
millions) 2547 4370 5400 2547 4270 5250 2547 3980 4900
CHD & Stroke 2265 4010 4970 2265 3920 4840 2265 3640 4510
Cancer 101 152 179 101 153 176 101 149 172
Scenario 0 = if BMI trends continue unabated; Scenario 1 = a 1% reduction in BMI
levels relative to scenario 0 and Scenario 2 = a 5% reduction in BMI levels relative
to scenario 0.
doi: 10.1371/journal.pone.0079827.t002
Figure 3.  Cumulative incident cases avoided per 100,000 population relative to scenario 0 (when scenario 1 and scenario 2
are applied).  This figure shows cumulative incident cases avoided per 100,000 population relative to scenario 0 when a 1%
decrease in BMI is applied to the Irish population (scenario 1) and a 5% decrease in BMI is applied to the Irish population (scenario
2).
doi: 10.1371/journal.pone.0079827.g003
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suggesting we may catch up with the US by 2030. It is
important to note that there have been plateau’s observed in
obesity levels in a selection of countries worldwide, were these
to occur in Ireland they would alter these projected trends
beneficially.
Strengths and Weaknesses
There are many unique aspects to this model; it is modular in
nature and capable of estimating the future effects of current
interventions. In addition it has the ability to process and
assimilate a wealth of data.
Like any research it also has its limitations. Recent increases
in childhood obesity have not been incorporated into the
projected adult obesity rates due to a lack of representative
data. Therefore the true prevalence of obesity in 2030 and
beyond is likely to be higher than that projected by the UK
foresight model. In addition, the direct healthcare costs of
childhood obesity have not been included in the burden
calculations.
The projections can only be as accurate as the data input
into the model and in many cases good quality healthcare data
is difficult to locate. Drug costs for cancer were not included as
recorded national data did not specify the cancer site or type.
UK proxies for hypertension prevalence and CHD & Stroke
survival were used in this paper due to unavailability of Irish
data in the desired format, highlighting the need for increased
health surveillance in Ireland. There are too few data points
available for Ireland but the estimates are still within 95% CI
and reliable up to 2020.
These projections are based on BMI trends in Ireland over
the last decade and recent past trends do not always predict
longer term future trends. While obesity has been increasing at
a steady pace over recent decades [1], future trends can be
shaped by new environments and technologies that cannot be
foreseen.
Conclusion
In this research we modelled three scenarios projecting the
consequences of no action and the impact of two separate
interventions to reduce BMI within the population. When
looking at healthcare research it is not the total cost of illness
that is important but rather determining if that cost is avoidable.
In the case of obesity the related disease burden and
subsequent healthcare costs are avoidable.
It is clear that a 5% reduction in overweight and obesity
(≥25kg/m2) levels will have a significant cost saving effect
(€495 million less being spent in obesity related direct
healthcare costs over the next twenty years). Governments,
health policy makers, public health personnel and the food and
drinks industry will now need agreement on how best to
achieve this attainable target. Ignoring this inevitable demise is
not an option if we have the interests of future generations at
heart.
In conclusion, this research provides evidence using a
recognised forecasting model of avoidable direct health care
costs for six major obesity related illnesses thereby providing
all those involved in healthcare provision with a platform from
which to work, as well as evidence of the likely consequence of
the ‘do nothing new’ scenario.
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